Biosensors and Molecular Technologies for Cancer Diagnostics (Series in Sensors)

Herold, Keith E.; Rasooly, Avraham

ISBN 10: 1439841659 / ISBN 13: 9781439841655

Edité par CRC Press (edition 1), 2012

A propos de cet article

It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting.

N° de réf. du vendeur 1439841659-8-1

Détails bibliographiques

• Titre: Biosensors and Molecular Technologies for Cancer Diagnostics (Series in Sensors)
• Éditeur: CRC Press (edition 1)
• Date de parution: 2012
• Langue: anglais
• ISBN à 10 chiffres: 1439841659
• ISBN à 13 chiffres: 9781439841655
• Reliure: Hardcover
• Édition: 1.
• État de l'article: Very Good

A propos de ce titre

Synopsis

Bridging the gap between research and clinical application, Biosensors and Molecular Technologies for Cancer Diagnostics explores the use of biosensors as effective alternatives to the current standard methods in cancer diagnosis and detection. It describes the major aspects involved in detecting and diagnosing cancer as well as the basic elements of biosensors and their applications in detection and diagnostics.

The book addresses cancer molecular diagnostics, including genomic and proteomic approaches, from the perspective of biosensors and biodetection. It explains how to measure and understand molecular markers using biosensors and discusses the medical advantages of rapid and accurate cancer diagnostics. It also describes optical, electrochemical, and optomechanical biosensor technologies, with a focus on cancer analysis and the clinical utility of these technologies for cancer detection, diagnostics, prognostics, and treatment.

Making biosensor technology more accessible to molecular biologists, oncologists, pathologists, and engineers, this volume advances the integration of this technology into mainstream clinical practice. Through its in-depth coverage of a range of biosensors, the book shows how they can play instrumental roles in the early molecular diagnosis of cancer.

À propos de l?auteur

Keith E. Herold is an associate professor in the Fischell Department of Bioengineering at the University of Maryland. A fellow of the ASME, Dr. Herold has over 10 years of experience in the analysis and testing of biosensor systems. His current research interests include bioMEMS, microfluidic systems for bioanalytical assays, and heat and mass transfer in bioengineering.

Avraham Rasooly is the chief of the Disparities Research Branch at the National Cancer Institute and a member of the Division of Biology in the Center for Devices and Radiological Health at the U.S. Food and Drug Administration.